These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 7194060

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)].
    Vorberg G, Ziegler WJ.
    Arzneimittelforschung; 1980; 30(11b):2068-72. PubMed ID: 7194062
    [Abstract] [Full Text] [Related]

  • 4. [On the uricosuric activity of etofylline clofibrate (author's transl)].
    Ziegler WJ.
    Arzneimittelforschung; 1980; 30(11b):2073-4. PubMed ID: 7194063
    [Abstract] [Full Text] [Related]

  • 5. [Clinical effects and tolerance of etofylline clofibrate].
    Ziegler WJ, Metz G, Specker M.
    Arzneimittelforschung; 1980; 30(11b):2053-8. PubMed ID: 7194059
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
    Sterner W, Chibanguza G, Metz G.
    Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
    [Abstract] [Full Text] [Related]

  • 8. Hypolipaemic activity of 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methylpropionate] (etofylline clofibrate) and its analogues in normolipaemic rats.
    Ginocchio AV, Metz G.
    Arzneimittelforschung; 1980; 30(11b):2032-4. PubMed ID: 7194054
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the hypolipaemic activity of etofylline clofibrate, a new ester of etofylline and clofibric acid, and comparison with effects of known hypolipaemic agents.
    Davies JE, Kellett DN.
    Arzneimittelforschung; 1980; 30(11b):2035-7. PubMed ID: 7194055
    [Abstract] [Full Text] [Related]

  • 10. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR, Klemens UH, Vollmar LJ, Lang PD.
    Med Klin; 1978 Dec 08; 73(49):1731-7. PubMed ID: 723760
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Chemistry of phenoxyacetic acid esters of oxyalkyltheophyllines and 1-(theophyllin-7-yl)-ethyl-2-[2-(p-chlorophenoxy)-2-methyl-propionate] (etofylline clofibrate), a novel antilipaemic agent (author's transl)].
    Metz G, Specker M.
    Arzneimittelforschung; 1980 Dec 08; 30(11b):2014-9. PubMed ID: 7194051
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Metabolism and pharmacokinetics of etofylline clofibrate, new antilipemic].
    Lücker PW, Wetzelsberger K, Erking W, Donike M.
    Arzneimittelforschung; 1980 Dec 08; 30(11b):2045-53. PubMed ID: 7194058
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T, Gries FA, Schwandt P, Weisweiler P, Hansen W, Nijssen J, Beckmann R.
    MMW Munch Med Wochenschr; 1977 May 20; 119(20):701-4. PubMed ID: 195201
    [Abstract] [Full Text] [Related]

  • 18. [Use of etofyllinclofibrate (Duolip Forte) in combined hyperlipidemia].
    Hrebícek J, Skottová N, Chmela Z, Hrbková M.
    Cas Lek Cesk; 1995 Mar 08; 134(5):141-4. PubMed ID: 7728839
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The effect of fenofibrate in various types of hyperlipoproteinemias].
    Sucić M.
    Lijec Vjesn; 1989 Mar 08; 111(3):93-7. PubMed ID: 2747411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.